FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions

Int J Mol Sci. 2019 Oct 8;20(19):4964. doi: 10.3390/ijms20194964.

Abstract

Anaphylaxis is an acute and life-threatening systemic reaction. Food, drug, aero-allergen and insect sting are known to induce anaphylaxis. Mast cells and basophils are known to mediate Immunoglobulin E (IgE)-dependent anaphylaxis, while macrophages, neutrophils and basophils mediate non IgE-dependent anaphylaxis. Histone deacetylases (HDACs) play various roles in biological processes by deacetylating histones and non-histones proteins. HDAC inhibitors can increase the acetylation of target proteins and affect various inflammatory diseases such as cancers and allergic diseases. HDAC3, a class I HDAC, is known to act as epigenetic and transcriptional regulators. It has been shown that HDAC3 can interact with the high-affinity Immunoglobulin E receptor (FcεRI), to mediate passive anaphylaxis and cellular interactions during passive anaphylaxis. Effects of HDAC3 on anaphylaxis, cellular interactions involving mast cells and macrophages during anaphylaxis, and any tumorigenic potential of cancer cells enhanced by mast cells will be discussed in this review. Roles of microRNAs that form negative feedback loops with hallmarks of anaphylaxis such as HDAC3 in anaphylaxis and cellular interactions will also be discussed. The roles of MCP1 regulated by HDAC3 in cellular interactions during anaphylaxis are discussed. Roles of exosomes in cellular interactions mediated by HDAC3 during anaphylaxis are also discussed. Thus, review might provide clues for development of drugs targeting passive anaphylaxis.

Keywords: Anaphylaxis, cellular interactions, FcεRI, HDAC3, MCP1, miRNAs.

Publication types

  • Review

MeSH terms

  • Anaphylaxis / drug therapy
  • Anaphylaxis / etiology*
  • Anaphylaxis / metabolism*
  • Animals
  • Cell Communication*
  • Chemokine CCL2 / metabolism*
  • Disease Susceptibility
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histone Deacetylases / metabolism*
  • Humans
  • Immunoglobulin E / immunology
  • Immunoglobulin G / immunology
  • MicroRNAs / genetics
  • Receptors, IgE / metabolism*
  • Signal Transduction*

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • Histone Deacetylase Inhibitors
  • Immunoglobulin G
  • MicroRNAs
  • Receptors, IgE
  • Immunoglobulin E
  • Histone Deacetylases
  • histone deacetylase 3